Piramal Snaps Up Peptide API Specialist Hemmo

Bolsters CDMO Business In Deal Worth More Than $100m

 
• By Dave Wallace

Piramal has announced a $106m deal to take full ownership of peptide API specialist Hemmo Pharmaceuticals, expanding its CDMO capabilities.

API Wooden Blocks Graphs
Piramal Pharma Solutions will gain peptide API capabilities from Hemmo • Source: Shutterstock

More from Deals

More from Business